Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01617-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Prediction of Adverse Events in Patients Receiving Rapid Rituximab Infusion

Clinical Journal of Oncology Nursing
Oncology
2014English

Safety of High-Dose Daptomycin in Patients With Severe Renal Impairment

Therapeutics and Clinical Risk Management
2018English

Continuous Hemodiafiltration With Polymyxin-B Immobilized Fiber Is Effective in Patients With Sepsis Syndrome and Acute Renal Failure

Therapeutic Apheresis and Dialysis
HematologyNephrology
2002English

Mesenchymal Stem Cell Infusion in Chronic Renal Failure Patients

Journal of Medical and Bioengineering
2015English

Hematological, Hepatic, and Renal Adverse Effects of High Dose Methotrexate Injection (50 Mg Weekly) in Severe Psoriasis Cases

Dermatology Reports
Dermatology
2019English

Leptotrichia Bacteremia in Patients Receiving High-Dose Chemotherapy

Journal of Clinical Microbiology
Microbiology
2011English

Double Blind Controlled Study of Low Dose Intravenous Perindoprilat or Enalaprilat Infusion in Elderly Patients With Heart Failure.

Heart
Cardiovascular MedicineCardiology
1993English

Pharmacokinetics of Daptomycin in a Patient With Severe Renal Failure Not Receiving Dialysis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Intravenous Infusion of Salbutamol in Severe Acute Asthma

BMJ
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy